Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study.
Yang ZY, Yuan F, Lu S, Xu W, Wu JW, Xi WQ, Shi M, Wang ZQ, Ni ZT, He CY, Yao XX, Zheng YN, Zhu ZL, Liu WT, Zhang J, Zhang H, Li C, Yan C, Yan M, Zhu ZG.
Yang ZY, et al. Among authors: yuan f.
Front Oncol. 2022 Jun 20;12:905922. doi: 10.3389/fonc.2022.905922. eCollection 2022.
Front Oncol. 2022.
PMID: 35795055
Free PMC article.